Article info

PDF

Research paper
Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study

Authors

  1. Correspondence to Professor Ludwig Kappos, Departments of Medicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital, Basel 4031, Switzerland; lkappos{at}uhbs.ch
View Full Text

Citation

Cohen JA, Khatri B, Barkhof F on behalf of the TRANSFORMS (TRial Assessing injectable interferoN vS. FTY720 Oral in RRMS) Study Group, et al
Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study

Publication history

  • Received February 25, 2015
  • Revised April 30, 2015
  • Accepted May 13, 2015
  • First published June 25, 2015.

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.